Spectrum

Three biopharma companies poised for product OKs in 2014: analyst
Marketwatch
Mon, 01/6/14 - 04:34 pm
Cubist
Regeneron
Spectrum
Steris buys surgical instrument repair duo for $110M
Mon, 10/22/12 - 09:48 pm
Steris
surgical
M&A
Spectrum
Spectrum: Increased Fusilev Production May Boost Stock
Seeking Alpha
Mon, 04/30/12 - 10:17 am
Spectrum
Fusilev
Abbott Laboratories
AstraZeneca
colorectal cancer
GSK
Biogen Idec
Eli Lilly
11 Biotech Bets For 2012
Seeking Alpha
Thu, 01/12/12 - 10:16 pm
Zalicus
Teva Pharmaceuticals
Spectrum
Astex
Aeterna Zentaris
Cel-Sci
Dendreon
Keryx
NPS Pharmaceuticals
Pharmacyclics
Questcor
Spectrum's Fusilev Sales Will Suffer As Leucovorin Shortage Is Eliminated
Seeking Alpha
Mon, 12/12/11 - 10:45 am
Spectrum
Fusilev
leucovorin
colon cancer
Spectrum Stock Tumbles 6% As Cancer Drug Threatened
Investor's Business Daily
Sat, 12/10/11 - 12:40 pm
Spectrum
Fusilev
generics
Spectrum Solidifies Long-Term Potential
Seeking Alpha
Thu, 09/22/11 - 08:28 am
Spectrum
Fusilev
colorectal cancer
Biotech Stocks Pains Continue As Outflows Persist
Forbes
Mon, 08/22/11 - 11:59 am
Biomarin
Regeneron
Spectrum
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
biotech
drug approvals
FDA
Eyelea
Regeneron
Dendreon
Provenge
NuPathe
Zelrix
Adcetris
Seattle Genetics
Soliris
Alexion
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
EXPAREL
Pacira
Roche
Zelboraf
Iluvien
Alimera
Bio-T-Gel
Teva Pharmaceuticals
BioSante
Zevalin
Spectrum
ruxolitinib
Incyte
Novartis
Pfizer
crizotinib
Antares
Anturol
Bydureon
Amlyin
Eli Lilly
Alkermes
AZ-004
Alexza
Corlux
Corcept Therapeutics
Affymax
Takeda
peginesatide
Levadex
MAP Pharmaceuticals